Ayala Pharmaceuticals Competitors and Similar CompaniesClear all
Ayala Pharmaceuticals's competitors and similar companies include Shanghai Henlius Biotech, United Therapeutics, Achieve Life Sciences and Immunovative Therapies.
 Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. |  Shanghai Henlius Biotech Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
|  United Therapeutics United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers. |  Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients. |  Immunovative Therapies Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases. | |
Founding Date | Founding Date 2017 | Founding Date 2009 | Founding Date 1996 | Founding Date 1995 | Founding Date 2004 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Wilmington, US HQ Rehovot, IL Wilmington, US | Locations HQ | Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US | Locations Seattle, US HQ Vancouver, CA Bothell, US Bothell, US | Locations Jerusalem, IL HQ |
Employees | Employees 29 | Employees 1273% increase | Employees 1,16819% increase | Employees 148% increase | Employees 6 |
Valuation ($) | Valuation ($) 7.4 m | Valuation ($) N/A | Valuation ($) 15.7 b | Valuation ($) 166.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $692k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $602k (FY, 2022) | Cost of goods N/A | Cost of goods $384.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $90k (FY, 2022) | Gross profit N/A | Gross profit $2.8b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($38m) (FY, 2022) | Net income N/A | Net income $1.3b (FY, 2025) | Net income ($54.6m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 47m | Total funding raised $ 346m | Total funding raised N/A | Total funding raised $ 10m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Shanghai Henlius Biotech
HQ
Employees
127↑ 3% increase
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
View companyUnited Therapeutics
HQ
Silver Spring, US
Employees
1,168↑ 19% increase
United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers.
View companyAchieve Life Sciences
HQ
Seattle, US
Employees
14↑ 8% increase
Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.
View companyImmunovative Therapies
HQ
Jerusalem, IL
Employees
6
Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases.
View company